All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Semaglutide Results After 4 Months: What to Expect

After 4 months on semaglutide, most patients lose 14 to 22 pounds and reach the higher dose range. Here is a complete timeline with clinical data and tips.

By Dr. Sarah Chen, PharmD|Reviewed by Dr. David Kim, MD, FACE||

Medically Reviewed

Written by Dr. Sarah Chen, PharmD · Reviewed by Dr. David Kim, MD, FACE

Semaglutide Results After 4 Months: What to Expect custom 2026 header image for GLP-1 Weight Loss
Custom header image for Semaglutide Results After 4 Months: What to Expect, GLP-1 Weight Loss, and better treatment decision-making.
In This Article

This article is part of our GLP-1 Weight Loss collection. See also: Provider Comparisons | Peptide Guides

Search and AI answer brief

Practical answer: Semaglutide Results After 4 Months: What to Expect

After 4 months on semaglutide, most patients lose 14 to 22 pounds and reach the higher dose range. Here is a complete timeline with clinical data and tips.

Short answer

After 4 months on semaglutide, most patients lose 14 to 22 pounds and reach the higher dose range. Here is a complete timeline with clinical data and tips.

Search intent

This page answers a specific GLP-1 Weight Loss question rather than a generic overview.

What to verify

semaglutide, tirzepatide, retatrutide, peptide evidence quality

How to use it

Use this information to prepare sharper questions for a licensed provider.

Key Takeaway

After 4 months on semaglutide, most patients lose 14 to 22 pounds and reach the higher dose range. Here is a complete timeline with clinical data and tips.

Four months on semaglutide is a milestone worth recognizing. If you're looking for semaglutide results after 4 months, you'll find that most patients have lost 14 to 22 pounds by this point, representing about 6% to 9% of their starting body weight . You're now at or approaching the higher dose range where the medication's full weight loss potential begins to emerge.

Dosing at Four Months

By week 16, most semaglutide patients are at 1.7 mg weekly (Wegovy dosing) or approaching the 2.0 mg maximum (Ozempic dosing) . This is a critical inflection point because:

  • 1.7 mg is the second-to-last step on the Wegovy ladder
  • Appetite suppression at this dose is considerably stronger than at 1.0 mg
  • Metabolic effects on blood sugar and lipids are near their peak
  • Weight loss rate is accelerating compared to earlier months

Monthly Progression Through Four Months

Months 1 to 2 Recap

You started at 0.25 mg and increased to 0.5 mg. Weight loss was gradual (5 to 9 pounds total), and your body adjusted to semaglutide's effects on appetite and digestion semaglutide results after 1 month. For a complete cost breakdown, see our compare GLP-1 providers.

GLP-1 Weight Loss Results by Medication Mean Body Weight Loss (%) 0 6 12 18 24 22 15 8 24 Tirzepatide Semaglutide Liraglutide Retatrutide Based on published STEP and SURMOUNT trial data
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
CategoryMean Body Weight Loss (%)Detail
Tirzepatide22~22% body weight at 72 wks
Semaglutide15~15% body weight at 68 wks
Liraglutide8~8% body weight at 56 wks
Retatrutide24~24% in Phase 2 trial
Illustration for Semaglutide Results After 4 Months: What to Expect

Month 3 Recap

At 1.0 mg, appetite suppression became powerful. Cumulative loss reached 10 to 15 pounds. Visible changes started drawing comments from those around you semaglutide results after 3 months.

Month 4: Near-Peak Dosing

Weeks 13 to 14: Stepping Up to 1.7 mg

  • This dose increase brings a strong jump in appetite suppression
  • Some patients report near-complete elimination of food noise
  • Mild nausea may return briefly (1 to 3 days) with the increase
  • Weekly weight loss of 1.5 to 2 pounds is common

Weeks 15 to 16: Adapting and Thriving

  • Body adjusts to 1.7 mg and side effects resolve
  • Total weight loss reaches 14 to 22 pounds
  • Clothing sizes typically drop by 1 to 2 sizes
  • Blood pressure and cholesterol readings continue improving
  • Exercise capacity is noticeably better with reduced weight

Four-Month Results Data

Outcome Typical Range at 4 Months
Total weight loss 14 to 22 pounds
Body weight percentage lost 6% to 9%
Waist circumference reduction 2.5 to 4 inches
Systolic blood pressure change 5 to 10 mmHg decrease
Triglyceride change 10% to 20% decrease
Current dose 1.7 mg weekly

The STEP 1 trial[1] showed approximately 8% to 9% body weight loss at week 16, with patients on the semaglutide 2.4 mg track . Patients at 1.7 mg are slightly behind that pace but well within the expected range, with additional weight loss expected as they reach the maintenance dose.

Check your GLP-1 eligibility

Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.

Try the BMI Calculator →

Side Effects at Four Months

Most patients are well-adapted to semaglutide by month four, but the 1.7 mg dose can bring some new considerations :

  • Nausea: Brief recurrence with dose increase, typically resolving in 2 to 3 days.
  • Constipation: May require ongoing management. Consider a fiber supplement plus 80+ ounces of water daily.
  • Fatigue: Caloric deficit from reduced appetite can cause low energy. Ensure you're eating enough protein and healthy fats.
  • Hair thinning: If present, it usually peaks around months 3 to 5 and resolves on its own. Biotin and a balanced diet support hair health.
  • Muscle loss: Without adequate protein and resistance training, weight loss can include lean muscle mass. This is preventable with proper nutrition and exercise.

Strategies for Month Four Success

  • Push protein to 100 to 120 grams daily. As your appetite decreases further, each meal needs to prioritize protein.
  • Strength train consistently. At least 3 sessions per week focused on major muscle groups.
  • Schedule a body composition scan. DEXA or InBody scans reveal whether you're losing fat vs. muscle.
  • Review your supplement stack. At minimum: multivitamin, vitamin D, omega-3, and potentially collagen peptides.
  • Set new goals. You have likely surpassed your initial goals. Work with your provider to set the next milestones FormBlends telehealth consultation.

Medical References

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]

Frequently Asked Questions

Is 14 to 22 pounds of weight loss at 4 months on track?

Yes. This represents 6% to 9% of body weight, which is consistent with clinical trial data. You still have room for significant additional loss as you approach or reach the 2.4 mg maintenance dose semaglutide results after 6 months.

When does semaglutide weight loss peak?

Most patients experience peak weight loss rate between months 4 and 8, with total weight loss continuing through months 12 to 15. After that, weight stabilizes at a new baseline .

Should I worry about losing muscle mass?

Muscle loss is a real concern during any significant weight loss. The best prevention is consuming adequate protein (at least 0.7 grams per pound of body weight daily) and performing resistance exercises 2 to 3 times per week .

Can I stay at 1.7 mg instead of going to 2.4 mg?

Some patients achieve their goals at 1.7 mg and stay there. Others benefit from the full 2.4 mg dose. Your provider will help determine the right dose based on your results, tolerability, and goals .

What happens if I hit a plateau at month four?

Plateaus are normal. Your body may be adjusting to a new setpoint. Solutions include increasing exercise, adjusting calorie intake, ensuring adequate sleep and stress management, and potentially advancing to a higher dose.

Research Snapshot

Provider comparison
Page type
Provider comparison
FormBlends review
Last reviewed
2026-04-01
FormBlends review
FormBlends official source
Official source
Ozempic evidence source
Official source
Retatrutide evidence source
Official source
Semaglutide evidence source
Official source
Tirzepatide evidence source
Official source
Wegovy evidence source
Official source
Before you act
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering

Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.

Evidence standard

How this page was source-checked

Editorial policy

FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.

PubMed evidence trail

Research sources used to frame this page

For Semaglutide Results After 4 Months: What to Expect, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Randomized trialSemaglutide evidence2021

Once-Weekly Semaglutide in Adults with Overweight or Obesity

Primary STEP 1 trial source for semaglutide weight-management efficacy and adverse-event context.

PubMed

Randomized trialSemaglutide evidence2021

Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance

Used for maintenance, discontinuation, and weight-regain discussions after semaglutide response.

PubMed

Randomized trialSemaglutide evidence2022

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight

Supports head-to-head context when pages compare older and newer GLP-1 options.

PubMed

Systematic reviewGLP-1 class evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.

PubMed

Systematic reviewGLP-1 class evidence2025

Discontinuing glucagon-like peptide-1 receptor agonists and body habitus

Used for pages discussing stopping therapy, weight regain, and long-term planning.

PubMed

Systematic reviewGLP-1 class evidence2025

Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition

Supports body-composition, lean-mass, and metabolic-risk context.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Emerging pharmacotherapies for obesity: A systematic review

Broad context for new and established obesity-drug categories.

PubMed

ReviewObesity pharmacotherapy evidence2026

Glucagon-like receptor agonists and next-generation incretin-based medications

Current review for incretin-based obesity medications and cardiometabolic effects.

PubMed

Systematic reviewObesity pharmacotherapy evidence2025

Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference

Used as a class-level evidence anchor when no more specific citation group matches.

PubMed

Provider decision path

Use local research to choose a safer review path

Direct answer

Semaglutide Results After 4 Months: What to Expect is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

FormBlends Editorial Context

Reviewed May 14, 2026

After 4 months on semaglutide, most patients lose 14 to 22 pounds and reach the higher dose range. Here is a complete timeline with clinical data and tips. "Semaglutide Results After 4 Months: What to Expect" is meant to make a complicated topic easier to discuss, not to flatten it into a one-size answer. FormBlends frames it around patient education and clinical context, with extra attention to semaglutide, dosing, provider access. Because this article has 6 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer. If the next step affects treatment or sourcing, use the article to prepare questions for a licensed clinician.

  • Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
  • Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
  • Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.

Original tools and data

Use the FormBlends research stack

These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.

Editorial refresh

Practical 2026 note for Semaglutide Results After 4 Months

This update makes Semaglutide Results After 4 Months more specific by tying semaglutide, tirzepatide, retatrutide, cash-pay pricing, safety signals, results to the page's original clinical, cost, access, or comparison angle.

The goal is to make the article more useful for people who already know the headline question and need page-level specifics, not another interchangeable glp-1 weight loss summary.

For 2026 review, the content emphasizes current verification, treatment fit, and patient-safety questions that can be discussed with a qualified provider.

Semaglutide Results After 4 Months custom 2026 image for glp-1 weight loss on FormBlends

Custom 2026 image for Semaglutide Results After 4 Months, glp-1 weight loss, and better treatment decision-making.

Image description: Unique image for this page covering Semaglutide Results After 4 Months, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.

Written by Dr. Sarah Chen, PharmD

Clinical Pharmacist. This article was researched against primary regulatory, trial, prescribing, and manufacturer sources where available. Reviewed by Dr. David Kim, MD, FACE for medical accuracy, sourcing, and patient-safety framing.

Ready to get started?

Provider-reviewed GLP-1 and peptide therapy, delivered to your door.

Start Your Consultation

Ready to Start Your Weight Loss Journey?

Get a free medical consultation with a licensed provider. Compounded GLP-1 medications starting at $99/month with free shipping.

Next Best Reads

Free Tools

Provider-informed calculators to support your weight loss journey.